Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
about
Optimal Use of Vaccines for Control of Influenza A Virus in SwineHarnessing Local Immunity for an Effective Universal Swine Influenza VaccineVaccine development for protecting swine against influenza virus.Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.Epidemic status of Swine influenza virus in china.Miniature Swine for Preclinical Modeling of Complexities of Human Disease for Translational Scientific Discovery and Accelerated Development of Therapies and Medical Devices.Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.Future vaccines for a globalized world.Principles underlying rational design of live attenuated influenza vaccines.Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza ChallengeComparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses
P2860
Q26783503-4623FC57-A0F7-4DE8-8534-F936AE6DF207Q30234558-EFD04B92-3B6C-4AAD-A9D7-0E1B60F1D2FEQ30424943-C9688D7B-9E49-4B93-8781-559F3B5A2EE3Q36276647-30EE53BD-DF19-4837-917A-2BE74EB49C96Q37123091-A6932499-6857-4C41-9A5C-D199CC2710EDQ37123473-367BC801-419A-4CAC-9692-E6E2D136D662Q37470805-D68D5797-11EC-4025-A603-991A10C8DDD4Q38721240-DAF84B09-5EC8-496F-A32B-1FE16226183DQ39248220-D7ADF080-A326-411D-BE3D-11041D9BEDDFQ39594585-DF62B9D8-7F96-4B13-A212-A6A9A0030D27Q39770895-350D1176-6DE1-43CF-9C68-B93F858603D5Q42373505-0493E902-B18A-4513-8CA3-2C41ACCAC027Q50308620-B1FA8436-321E-451C-A6E8-4DFAA0D7C010Q58583885-EA12926F-C01E-45F8-817F-6FE98F351E20Q58706119-9AF6FA4D-8D40-4627-A41C-DED45FF69979
P2860
Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Immunogenicity and protective ...... nistered intranasally in pigs.
@en
Immunogenicity and protective ...... nistered intranasally in pigs.
@nl
type
label
Immunogenicity and protective ...... nistered intranasally in pigs.
@en
Immunogenicity and protective ...... nistered intranasally in pigs.
@nl
prefLabel
Immunogenicity and protective ...... nistered intranasally in pigs.
@en
Immunogenicity and protective ...... nistered intranasally in pigs.
@nl
P2093
P1433
P1476
Immunogenicity and protective ...... nistered intranasally in pigs.
@en
P2093
Aleksandar Masic
Earl G Brown
George K Mutwiri
Lorne A Babiuk
P304
P356
10.1016/J.VACCINE.2010.08.003
P407
P577
2010-08-12T00:00:00Z